1. Home
  2. KALU vs STOK Comparison

KALU vs STOK Comparison

Compare KALU & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KALU
  • STOK
  • Stock Information
  • Founded
  • KALU 1946
  • STOK 2014
  • Country
  • KALU United States
  • STOK United States
  • Employees
  • KALU N/A
  • STOK N/A
  • Industry
  • KALU Metal Fabrications
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • KALU Industrials
  • STOK Health Care
  • Exchange
  • KALU Nasdaq
  • STOK Nasdaq
  • Market Cap
  • KALU 1.3B
  • STOK 1.3B
  • IPO Year
  • KALU 1991
  • STOK 2019
  • Fundamental
  • Price
  • KALU $92.65
  • STOK $25.14
  • Analyst Decision
  • KALU Buy
  • STOK Strong Buy
  • Analyst Count
  • KALU 3
  • STOK 8
  • Target Price
  • KALU $95.67
  • STOK $30.00
  • AVG Volume (30 Days)
  • KALU 206.7K
  • STOK 1.5M
  • Earning Date
  • KALU 10-22-2025
  • STOK 11-04-2025
  • Dividend Yield
  • KALU 3.30%
  • STOK N/A
  • EPS Growth
  • KALU 58.01
  • STOK N/A
  • EPS
  • KALU 5.17
  • STOK 0.91
  • Revenue
  • KALU $3,209,400,000.00
  • STOK $199,893,000.00
  • Revenue This Year
  • KALU $12.63
  • STOK $416.54
  • Revenue Next Year
  • KALU $11.42
  • STOK N/A
  • P/E Ratio
  • KALU $18.03
  • STOK $28.59
  • Revenue Growth
  • KALU 7.69
  • STOK 1218.82
  • 52 Week Low
  • KALU $46.81
  • STOK $5.35
  • 52 Week High
  • KALU $97.60
  • STOK $38.69
  • Technical
  • Relative Strength Index (RSI)
  • KALU 62.46
  • STOK 36.59
  • Support Level
  • KALU $87.89
  • STOK $24.50
  • Resistance Level
  • KALU $93.91
  • STOK $33.88
  • Average True Range (ATR)
  • KALU 3.76
  • STOK 2.36
  • MACD
  • KALU 0.64
  • STOK -1.25
  • Stochastic Oscillator
  • KALU 73.72
  • STOK 5.31

About KALU Kaiser Aluminum Corporation

Kaiser Aluminum Corp produces and sells semi-fabricated specialty aluminum products predominantly to industrial customers. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: